secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLARGO, INC. (BLGO)
CIK:        0000880242
Form:       8-K/A
Filed at:   2026-09-11T23:42:38+00:00
Accession:  0001437749-26-030198
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLargo Q2 2026 earnings town hall held; figures not visible in filing excerpt
-------------------------------------------------------------------------------

- BioLargo held Q2 2026 earnings call Sept 10, 2026 with CEO Dennis Calvert and CFO Charles Dargan.
- No revenue, EPS, or guidance figures appear in the provided transcript excerpt; it cuts off at safe harbor language.
- Investor relations contact Matt Kreps of Darrow Associates introduced the shareholder town hall.
- Company addressed pre-submitted shareholder questions during the call; financial detail unavailable from this excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/880242/000143774926030198/0001437749-26-030198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/880242/000143774926030198/blgo20260911_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-030198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer